Pharma

Los Angeles-based mobile clinical trials company Science 37 has raised $6.

Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from  Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures.

Propeller Health is working with Boehringer Ingelheim.

MedWatcher, from Epidemico.

Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.

Voluntis's Diabeo app, not available in the United States French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.

Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company.

Iodine, the crowdsourced drug review startup that launched last year, is continuing to focus on antidepressants.

Merck Sharpe and Dohme (MSD), the UK subsidiary of US pharma company Merck and Co.

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments.